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Edited by Shou-Wei DingAbstract MicroRNAs (miRNAs) are small non-coding RNA
molecules that post-transcriptionally regulate gene expression
by base-pairing to mRNAs. Hundreds of miRNAs have been
identiﬁed in various multicellular organisms and many miRNAs
are evolutionarily conserved. Although the biological functions of
most miRNAs are unknown, miRNAs are predicted to regulate
up to 30% of the genes within the human genome. Gradually,
we are beginning to understand the functions of individual
miRNAs and the general function of miRNA action. Here, we
review the recent advances in miRNA biology in animals. Partic-
ularly, we focus on the roles of miRNAs in vertebrate develop-
ment and disease.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The founding microRNA, lin-4, was ﬁrst thought to be an
isolated case. The lin-4 gene was identiﬁed by genetics in the
nematode Caenorhabditis elegans (C. elegans) and is involved
in developmental timing. Surprisingly, this gene does not
encode a protein but codes for two small RNA molecules of
60 and 22 nucleotides in length [1]. The former is the pre-
cursor of the smaller and can form a secondary stem-loop
structure that is phylogenetically conserved in nematodes.
The smaller RNA molecule regulates the lin-14 gene by base-
paring to imperfect complementary sites in the 3 0 untranslated
region (UTR) of lin-14mRNA [2]. This form of post-transcrip-
tional gene silencing by a small regulatory RNA was initially
regarded as a rare phenomenon, speciﬁc for nematodes. How-
ever, the discovery of let-7 changed this idea. Let-7 is another
small RNA that is also involved in developmental timing in
C. elegans and regulates the lin-41 gene [3,4]. Hence, lin-4
and let-7 were both called small temporal RNAs (stRNAs)
for their role in developmental timing [5]. In contrast to the
lin-4/lin-14 pair, let-7 and lin-41 are evolutionarily conserved
among a wide variety of multicellular organisms. Furthermore,
let-7 is also diﬀerentially expressed during development of
various bilaterian animals [5]. This discovery implied that*Corresponding author. Fax: +31302516554.
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doi:10.1016/j.febslet.2005.07.070regulation of gene expression by these small RNAs was not
restricted to nematodes and could be a general mechanism
present in many multicellular organisms. Indeed, almost one
hundred of such small regulatory RNAs were readily identiﬁed
in C. elegans, Drosophila and human [6–8]. Since most of these
newly identiﬁed small RNAs are not expressed in a temporal-
speciﬁc manner, as lin-4 or let-7, but in a spatial- or tissue-
speciﬁc manner, the small regulatory RNAs are now called
microRNAs (miRNAs). Currently, miRNAs have been identi-
ﬁed in many other multicellular organisms, and it is estimated
that vertebrate genomes may encode several hundred or per-
haps up to 1000 diﬀerent miRNAs [9,10], which may regulate
up to 20–30% of the genes [10,11]. Here, we review the recent
advances in miRNA identiﬁcation, expression and function in
animals. Particularly, we focus on the roles of miRNAs in ver-
tebrate development and disease. A similar review on plant
miRNAs can be found elsewhere in this issue of FEBS Letters
[12].2. Identiﬁcation and expression of miRNAs
2.1. Identiﬁcation of miRNAs
Currently, 2909 miRNA genes have been annotated in miR-
Base (release 7.0) [13]. To annotate a newly identiﬁed small
RNA as miRNA it must fulﬁll several criteria. First, miRNAs
are expressed as 22-nucleotide RNA molecules. Second,
miRNAs are encoded in the genome as phylogenetically
conserved hairpin structures with a low free energy. Third,
miRNA expression levels are reduced in animals defective in
miRNA biogenesis [14]. It is worth noting that not all miRNAs
exactly ﬁt these criteria. In particular, the requirements for
annotation of closely related miRNAs in miRNA families or
other species is less stringent [14]. Members of the miRNA
gene class in animals are identiﬁed in several ways (Fig. 1).
The founding members, lin-4 and let-7, were both identiﬁed
in C. elegans based on their mutant phenotypes in forward
genetic screens [1,3]. Other forward genetic screens have only
led to the identiﬁcation of one additional miRNA in C. elegans
(lsy-6 [15]) and two additional miRNAs in Drosophila (bantam
and miR-14 [16,17]). Although small in number, these ﬁve
miRNAs are probably the best-studied miRNAs so far. The
unbiased nature of forward genetics screens can discover
miRNAs that cannot easily be detected by any other method.
For example, the lsy-6 miRNA could not be identiﬁed by
either cDNA cloning nor computational predictions [15]. On
the other hand, many miRNAs are likely to be missed in
forward genetic screens because miRNA genes are relativelyblished by Elsevier B.V. All rights reserved.
Fig. 1. Approaches for the identiﬁcation of miRNA genes, target genes and functions of miRNAs in animals. For each approach an example
miRNA is given that is mentioned in the text or literature. Abbreviations. Ce, Caenorhabditis elegans; Dm, Drosophila melanogaster; Dr, Danio rerio
(zebraﬁsh); Hs, Homo Sapiens; Mm, Mus musculus.
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coding gene), which are not often hit by the classical mutagens.
In addition, many miRNAs might have redundant functions
and therefore give only very subtle or no phenotypes when
mutated [18].
To bypass the rare genetic discovery of miRNAs, several
labs identiﬁed more than a hundred miRNAs by cDNA
cloning and subsequent sequence analysis [6–8,19]. This
approach has the advantage that it can be applied to any
organism, even if little or no genomic information is available.
In addition, miRNAs can be identiﬁed independent of their
function, thus also allowing the identiﬁcation of redundant
miRNAs. By cDNA cloning, miRNAs have now been identi-
ﬁed in diverse animals like nematodes [6,8,20], ﬂies [7,21],
mammals [7,22–28], frogs [29], ﬁsh [30,31] and several mamma-
lian viruses [32,33].
One limitation of the cloning strategy is that there is a poten-
tial bias in cloning small RNA molecules. Highly expressed
miRNAs or technically easy to clone miRNAs might over-
shadow the miRNAs that are only expressed at particular
developmental stages, under speciﬁc circumstances, in speciﬁc
cell types or which are otherwise diﬃcult to clone. To over-
come such a bias, several computational algorithms have been
developed to predict miRNAs in nematode, ﬂy and vertebrate
genomes [20,30,34–38]. These approaches use genome compar-
isons to search for evolutionary conserved hairpin structures,
which could encode precursor miRNAs (pre-miRNAs).
Together, these algorithms predict that there are 110
miRNAs in the Drosophila genome, 120–300 miRNAs in
the C. elegans genome, and 255 miRNAs in vertebrate gen-
omes such as human [20,30,34–37]. However, more recently
three independent computational approaches indicate that
the actual number of miRNAs in vertebrates might be much
higher [9,10,39]. We found, by phylogenetic shadowing of pri-
mate miRNAs, that there is a high degree of conservation in
miRNA regions, but relatively low conservation in sequences
immediately ﬂanking these regions (see Fig. 2A for example).
This feature was used to predict over 800 new miRNAs in
mammalian genomes of which many are conserved in other
vertebrate genomes. The expression of some (16) of these
predicted miRNAs could be conﬁrmed experimentally [9].Xie and coworkers searched for conserved motifs in 3 0 UTRs
by systematic comparison of several mammalian genomes.
More than half of the recovered motifs correspond with the
seed sequences (nucleotide positions 2–8) of known miRNAs.
The remaining motifs were used to predict 129 new miRNAs
[10]. Finally, Bentwich et al. [39] used an integrative approach,
combining bioinformatic predictions with microarray analysis
and sequence-directed cloning, to identify 89 new miRNAs
and predict the total number of human miRNAs to be at least
800. Together, these studies predict that the total number of
miRNAs in vertebrate genomes might be doubled and maybe
approach as many as 1000 [9]. These candidate miRNAs
require further experimental veriﬁcation.
2.2. Expression of miRNAs
The distribution of miRNA genes within genomes is not ran-
dom. More than half of known mammalian miRNA genes are
within introns of host genes [40]. Microarray analysis indicates
that many of these miRNAs are coexpressed with their host
genes [41]. The location of some of these intronic miRNAs is
evolutionarily conserved and they are similarly coexpressed
with their host genes in diﬀerent animals. For example, the
mir-126 gene is located in an intron of the EGFL7 gene of
mouse, human [40] and zebraﬁsh. miR-126 and EGFL7 are
similarly expressed in endothelial cells of the heart and blood
vessels in both humans and zebraﬁsh [41,42]. Such homologies
suggest important and evolutionarily conserved roles for these
miRNAs. Approximately 40% of human miRNA genes are in
genomic clusters. Many of these miRNAs are also coexpressed
[41], which could have biological advantages. Finally, miRNA
genes are frequently located at fragile sites and genomic
regions involved in cancers [43], suggesting that these miRNAs
are involved in cellular processes impaired in cancers, such as
cell growth, cell division and proliferation.
miRNAs have a wide variety of expression patterns. In C.
elegans and Drosophila some miRNAs are diﬀerentially
expressed in time during development, whereas others seem
to be more ubiquitously expressed [5–8,20,21,34,37,44]. For
most of these miRNAs only the temporal expression patterns
have been determined. However, reporter constructs show that
some miRNAs are only expressed in speciﬁc cell types [15,45].
Fig. 2. Vertebrate miRNAs in zebraﬁsh. (A) Phylogentic conservation of two clustered vertebrate miRNA genes. miRNA regions (indicated by the
red boxes) are more conserved than ﬂanking sequences. See [9] for details. (B) Example expression patterns of conserved brain-speciﬁc miRNAs in
zebraﬁsh embryos. Adapted with permission from [42].
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in vertebrates. First, the cloning frequency from particular
tissues or cells is diﬀerent for many miRNAs. For example,
several miRNAs are predominantly cloned from mouse heart,
liver or brain tissues [23], embryonic stem cells [27,28] or pan-
creatic islet cells [46]. Further analysis by northern blots or
microarrays reveals that many other vertebrate miRNAs are
also tissue-speciﬁcally expressed [41,42,47–51]. Our recent data
from in situ hybridizations in zebraﬁsh embryos indicate that
80% of the conserved vertebrate miRNAs that are expressed
during embryonic development are tissue-speciﬁc. This tissue-
speciﬁcity is not restricted to only a few major organs, but
virtually all zebraﬁsh tissues and even individual cell types
within tissues have speciﬁc expression of one or a few
miRNAs. For example, miR-183 is speciﬁcally expressed in
the hair cells of sensory epithelia [42]. This high number of
tissue-speciﬁc miRNA expression patterns suggests that these
miRNAs have a role in tissue diﬀerentiation.
Many miRNAs are similarly expressed in mammals and
zebraﬁsh, indicating an evolutionarily conserved function.
For example, many miRNAs that are brain-speciﬁc in mam-
mals have very distinct in situ expression patterns in the brain
of zebraﬁsh embryos (e.g., see Fig. 2B [42]). In addition, these
miRNAs are also diﬀerentially expressed during mammalian
brain development [26,52], suggesting a conserved role in
vertebrate brain function.3. miRNA biogenesis and mechanism
The mammalian miRNA biogenesis pathway (and that of
other animals) can be divided into multiple steps (Fig. 3). Ini-tially, miRNA genes are transcribed byRNApolymerase II into
long primary miRNAs (pri-miRNAs) [53,54]. The processing of
these pri-miRNAs into the ﬁnal mature miRNAs occurs step-
wise and compartmentalized [55]. pri-miRNAs are processed
in the nucleus into 70–80-nucleotide precursor miRNAs
(pre-miRNAs) by the RNase III enzyme Drosha [56] Drosha
forms a microprocessor complex with double-stranded
RNA-binding protein DGCR8 (Pasha in ﬂies) [57–60]. pre-
miRNA hairpins are exported from the nucleus by Exportin-5
in the presence of Ran-GTP as cofactor [61–63]. In the cyto-
plasm, the pre-miRNAs are processed into 22-nucleotide du-
plexmiRNAs by theRNase III enzymeDicer [64–66]. Dicer was
originally discovered by its role in RNA interference (RNAi) in
which it processes long double-stranded RNA into small inter-
fering RNAs (siRNAs) that mediate RNAi [67–70]. Dicer inter-
acts with the double-stranded RNA-binding protein TRBP
(RDE-4 in C. elegans and Loquacious in Drosophila [71–75]),
which likely bridges the initiator and eﬀector steps of miRNA
action. Next, miRNA duplexes are unwound, which starts at
the duplex end with the lowest thermodynamic stability. The
miRNA strand that has its 5 0 terminus at this end is the future
mature miRNA (also called guide RNA) [76–78].
The mature miRNAs are incorporated into a ribonucleopro-
tein complex, miRNP [25,79], which is similar, though not
necessarily identical, to the RNA-induced silencing complex
(RISC), the eﬀector of RNAi [80]. In RISC, miRNAs can
mediate downregulation of target gene activity by two modes:
translational inhibition or target mRNA cleavage (Fig. 3).
The choice is made based on the degree of complementarity
between the miRNA and target gene in combination with an
Argonaute family protein. Near-perfect complementarity
results in cleavage, followed by general RNA degradation of
Fig. 3. A model for the miRNA biogenesis pathway and mechanism in mammals. See text for details.
5914 E. Wienholds, R.H.A. Plasterk / FEBS Letters 579 (2005) 5911–5922the targets, whereas partial complementarity causes transla-
tional inhibition [79,81–84]. The exact mechanism for transla-
tional inhibition is not known. miRNA-targeted mRNAs
could, for example, be sequestered on polysomes [85,86] or be
recruited to P-bodies where they are depleted of the translation
machinery and eventually degraded [87,88]. In contrast to
plants, miRNA-directed cleavage in animals (such as the cleav-
age of HOXB8 mRNA by miR-196 in mouse embryos [89,90])
is less common than translational inhibition. Argonaute
proteins are prominently present in RISC and all mammalian
Argonaute proteins bind miRNAs and siRNAs. However, in
both mammals andDrosophilaArgonaute2 (eIF2C2) is the sole
catalytic engine of RISC that mediates targeted RNA cleavage
[70,91–93]. Furthermore, Drosophila Argonaute1 and the two
Argonaute1 homologs alg-1 and alg-2 in C. elegans are required
for miRNA production, stability and function [65,94].4. Biological functions of miRNAs in animals
miRNAs have diverse biological functions (Table 1). Clues
about the function of miRNAs in animals have been obtained
by several approaches (Fig. 1). First, several miRNAs were
identiﬁed by loss- and gain-of-function genetic screens inC. elegans and Drosophila. Since these miRNAs were found
based on their biological functions, their described functions
are likely the most accurate. Other genetically assigned
miRNA functions come from reverse genetic approaches.
These approaches include miRNA knockout or knockdown
[95–98] and miRNA overexpression studies. Furthermore,
the miRNA expression proﬁles, determined by, for example,
microarray- and in situ analysis, have revealed speciﬁc miRNA
expression patterns, which give hints to the functions of
speciﬁc miRNAs.
miRNAs function through the regulation of target genes.
Only a few (seven) of the miRNA target genes have been iden-
tiﬁed genetically by forward and reverse genetic screens. Most
miRNA target genes come from computational predictions.
However, only a handful of these predicted targets have been
experimentally validated in Drosophila and human cells using
reporter constructs and the majority remains to be veriﬁed
[38,99]. Recent miRNA target predictions indicate that for
each Drosophila miRNA there are on average 100 diﬀerent
target genes of which most are regulated through the seed site
interactions [100]. miRNA target predictions in mammals indi-
cate that 10–30% of the genes might be under control of the
currently known miRNAs [10,11,101] and that each mamma-
lian miRNA regulates on average 200 target genes through
Table 1
Biological functions of miRNAs in animals and disease
miRNA Target(s) Function(s) References
Ceanorhabditis elegans
lin-4 lin-14, lin-28 Early developmental timing [1,106,107]
let-7 lin-41, hbl-1, daf-12 pha-4, ras Late developmental timing [3,4,108–111]
lsy-6 cog-1 Left/right neuronal asymmetry [15]
miR-273 die-1 Left/right neuronal asymmetry [112]
Drosophila melanogaster
bantam hid Programmed cell death [16]
miR-14 Drice? Programmed cell death and fat metabolism [17]
miR-7 Notch targets? Notch signaling [113,115]
Danio rerio
miR-430 ? Brain morphogenesis [120]
Mus musculus
miR-196 Hoxb8 Developmental patterning [90]
miR-181 ? Hematopoietic lineage diﬀerentiation [47]
miR-1 Hand2 Cardiomyocyte diﬀerentiation and proliferation [122]
miR-375 Mtpn Insulin secretion [46]
Human and other vertebrate cell lines
miR-16 Several AU-rich element-mediated mRNA instability [130]
miR-32 Retrovirus PFV-1 Anitviral defense [97]
miR-143 Erk5? Adipocyte diﬀerentiation [123]
SVmiRNAs SV40 viral mRNAs Susceptibility to cytotoxic T cells [145]
Cancer in humans
miR-15-miR-16 ? Downregulated in B-cell chronic lymphocyte leukemia [137]
miR-143, miR-145 ? Downregulated in colonic adenocarcinoma [138]
miR-155/BIC ? Upregulated in diﬀuse large B-cell lymphoma [139,140]
let-7 Ras? Downregulated in lung cell carcinoma [111,141]
miR-17-92 ? Upregulated in B-cell lymphoma [142]
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target site [102]. Many genes have several target sites for either
one miRNA or a few diﬀerent miRNAs. In some cases, multi-
ple target sites are essential for proper regulation in vitro or
in vivo [100,102–105]. The combinatorial regulation by diﬀer-
ent miRNAs adds another layer of complexity that can result
in more ﬁne-tuned activity in diverse cell-types, similar to the
combinatorial regulation by diﬀerent transcription factors.
4.1. Developmental timing in worms
The two best-studied miRNAs, lin-4 and let-7, were found
by forward genetics to act in the heterochronic pathway to
regulate developmental timing in C. elegans [1,3]. Let-7 was
identiﬁed as a suppressor of lin-14 mutants [3], indicating that
they act in the same pathway. Loss-of-function mutations in
lin-4 and let-7 both cause retarded development but at diﬀerent
developmental stages. Whereas lin-4 null mutants reiterate
speciﬁc fates of the ﬁrst larval stage at subsequent later stages,
let-7 null mutants reiterate larval cell fates at the adult stage.
Conversely, overexpression of let-7 gives precocious develop-
ment, the opposite heterochronic phenotype [3]. The timing
of the phenotypes corresponds with the onset of lin-4 and
let-7 expression, which is early and late in development, respec-
tively [1,3]. Thus, lin-4 is an early developmental timer and
let-7 a late developmental timer.
Two lin-4 targets, lin-14 and lin-28, were both identiﬁed as
genes that act downstream of lin-4 in the heterochronic
pathway. Loss-of-function mutations in these genes cause
phenotypes that are opposite to that of lin-4 mutants: preco-
cious cell fates of late developmental stages during the ﬁrstand second larval stages [2,106]. Furthermore, gain-of-func-
tion mutations in the lin-14 3 0 UTR cause a phenotype similar
to lin-4 loss-of-function mutations [107]. Lin-14 encodes a
nuclear protein, which regulates the transition from the ﬁrst
to the second larval stage [2]. Lin-28 encodes a cold-shock zinc
ﬁnger protein that promotes the transition of the second to
third larval stage [106]. Regulation by lin-4 might not be
restricted to the early stages since it is also required for down-
regulation of a hbl-1::GFP reporter gene, which has target sites
for both lin-4 and let-7 in its 3 0 UTR, in ventral nerve cord
neurons of adults [108].
Multiple genes are regulated by let-7 in tissue-speciﬁc man-
ners. The lin-41 target gene was identiﬁed in a genetic screen
as strongest suppressor of the lethality of let-7 mutants. It
encodes a RBCC (ring ﬁnger, B box, coiled coil) protein. Null
mutations in lin-41 cause the opposite phenotype to that of the
let-7 mutants, namely precocious expression of adult fates at
larval stages [3,4]. Overexpression of wild-type lin-41 results
in reiteration of larval fates, similar to let-7 loss-of-function
mutants [4]. Lin-41 is partially redundant with the hunch-
back-like gene hbl-1 in the hypodermal seam cells and nega-
tively regulates the timing of the adult speciﬁcation
transcription factor LIN-29 [108,109]. The defects in let-7
mutant strains are also suppressed by loss of hbl-1 function.
Hbl-1 is involved in timing events in neurons of the ventral
nerve cord and vulval cells [108,109]. Several other targets
for let-7 have been identiﬁed in an RNAi knockdown screen
for genes that have let-7 target sites and suppress let-7 mutant
lethality. This yielded the nuclear hormone receptor daf-12,
which is another target in seam cells of the hypodermis and
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target. It also identiﬁed the zinc ﬁnger transcription factor
die-1, the putative chromatin remodeling factor lss-4 and the
RAS ortholog let-60 as probable targets [110]. In addition,
recent experiments indicate that let-60/RAS is regulated by
let-7 in the hypodermal cells and by the let-7 family member
miR-84 in vulval cells [111].4.2. Neuronal left/right asymmetry in worms
A cascade of genes, involving two miRNAs, determines the
left/right asymmetric expression of chemosensory receptor
genes in the left (ASEL) and right (ASER) chemosensory neu-
rons of C. elegans [15,112]. The lsy-6 miRNA is expressed in
the ASEL neuron and inhibits the expression of its target,
the Nkx-type homeobox gene cog-1. This ultimately leads to
the expression of the GCY-7 chemosensory receptor in ASEL
[15]. In the ASER neuron, miR-273 inhibits the translation of
die-1 mRNA. DIE-1 is a zinc-ﬁnger transcription factor
needed for the transcription of lsy-6. Therefore, the expression
of miR-273 leads to the downregulation of lsy-6 and subse-
quently to the expression of the GCY-5 chemosensory receptor
in ASER [112]. Thus, inverse and sequential expression of two
miRNAs leads to asymmetric expression of chemosensory
receptors in neurons of C. elegans.4.3. Programmed cell death in ﬂies
In Drosophila, two miRNAs, bantam and miR-14, were
genetically found to be involved in the regulation of progra-
mmed (apoptotic) cell death. The bantam miRNA was identi-
ﬁed in a gain-of-function EP element insertion screen for genes
that aﬀect cell proliferation. Overexpression of bantam causes
tissue overgrowth and inhibits proliferation-induced apoptosis
[16]. In contrast, loss of bantam function is lethal. Bantam
negatively regulates Hid protein expression in vivo and thereby
blocks hid-induced apoptostis in the eye [16]. miR-14 was iden-
tiﬁed by a genetic screen for inhibitors of programmed cell
death. Animals with miR-14 loss-of-function alleles have
enhanced Reaper-induced cell death, whereas overexpression
of miR-14 suppresses cell death. The absence of miR-14 is also
characterized by semilethality, reduced lifespan and stress sen-
sitivity. Furthermore, miR-14 is involved in the regulation of
fat metabolism in a dose-dependent manner [17]. A potential
target for miR-14 is the apoptotic eﬀector caspase Drice. Drice
is upregulated in the absence of miR-14, suggesting that the
drice mRNA is regulated, either directly or indirectly, by
miR-14 [17]. Other miRNAs that potentially act in the pro-
grammed cell death pathway are miR-2 and miR-13. They
are predicted to regulate the proapoptotic genes reaper, grim
and sickle [113]. miR-2 downregulates reporter constructs with
the 3 0 UTRs of these target genes in vitro and in vivo [113].
Furthermore, knockdown of miR-2 or miR-13 may give deve-
lopmental defects [114].4.4. Notch signaling in ﬂies
Several miRNAs may be involved in regulating the Notch
signaling pathway. Notch signaling is essential for proper pat-
terning and development of all multicellular organisms. In
Drosophila, the Notch target genes, encoding basic helix–
loop–helix (bHLH) repressors and Bearded family proteins,
are post-transcriptionally regulated by diﬀerent combinations
of the K-box, GY-box and Brd-box motifs in their 3 0 UTRs.These 6–7 nt motifs are evolutionary conserved [113,115] and
are complementary to the seed sequences of several miRNAs
[116]. Reporter constructs with the 3 0 UTRs of the bHLH
and Bearded Notch target genes are downregulated by multiple
members of miRNA families in vivo [113,115]. The individual
K-boxes, GY-boxes or Brd-boxes are necessary and suﬃcient
for this miRNA-mediated regulation. The K-box is regulated
by miR-2 and miR-11, the GY-box by miR-7, and the
Brd-box by miR-4 and miR-79 [115]. Ectopic overexpression
of miR-7 or a cluster of K-box-regulating miRNAs leads to
reduced expression of downstream notch targets such as Cut.
Furthermore, it causes notching of the wing margin, reduced
wing vein spacing, thickening of the wing veins and ectopic
microchaete bristles [113,115]. These phenotypes are characte-
ristic of reduced Notch signaling, supporting the idea that the
Notch signaling pathway is regulated by miRNAs.4.5. Early vertebrate development
Several observations show that miRNAs are essential for the
normal development of mammals. First, mouse and human ES
cells express a speciﬁc set of miRNAs that are downregulated
upon diﬀerentiation into embryoid bodies [27,28]. Second, ES
cells that are deﬁcient in dicer are viable, but do not form ma-
ture miRNAs and they fail to diﬀerentiate in vitro and in vivo
[117]. Third, dicer mutant mouse embryos die before axis for-
mation during gastrulation and have ES cell loss [118].
To study the global role of miRNAs in early embryonic
development we knocked out the dicer gene in zebraﬁsh
[119]. Zebraﬁsh embryos that are dicer mutant develop nor-
mally but arrest 8 days after fertilization when they run
out of maternal Dicer and are depleted of mature miRNAs.
At this point all the major organs have been formed. This
arrest suggests that miRNAs are essential for development
and growth of tissues beyond this stage. Knockdown of
maternal Dicer mRNA by morpholinos results in an earlier
arrest and delay in miRNA production. However, during
the ﬁrst 24 h, these embryos still develop quite normally,
which indicates that miRNAs are not essential for earliest
developmental processes [119]. To also exclude a role for
maternal Dicer protein Giraldez et al. [120] generated mater-
nal-zygotic mutants from the dicer knockout zebraﬁsh. As
expected, these maternal-zygotic dicer mutants do not process
pre-miRNAs into mature miRNAs. Surprisingly, they have
only some mild defects during early development. They have
intact axis formation and cell regionalization and diﬀerentiate
into multiple cell types and tissues, indicating correct pattern-
ing. However, they show morphogenesis defects during
gastrulation, brain formation, neural diﬀerentiation, somito-
genesis and heart development. Together, this implies that
miRNAs are not essential for cell fate determination and
early patterning, but are essential for subsequent later steps
in embryonic development [120]. This notion is further
supported by the temporal and spatial expression patterns
of conserved vertebrate miRNAs in zebraﬁsh embryos
[31,42]. The majority of these miRNAs are not expressed
early, but show highly tissue-speciﬁc expression during the la-
ter stages [31,42], suggesting that their role is not in tissue
fate establishment but in diﬀerentiation or maintenance of tis-
sue identity [31,42]. Interestingly, dicer mutant primordial
germ cells give rise to viable germ lines in both male and
female zebraﬁsh, which can form embryos. This indicates that
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gametes during germ-line development in zebraﬁsh [120].
Why do dicer mutant mouse embryos without mature
miRNAs die before axis formation while zebraﬁsh dicer
mutant embryos without mature miRNAs survive that stage?
This may be explained by the diﬀerences in dynamics during
early embryonic development. Compared to mouse develop-
ment zebraﬁsh early development is extremely rapid. One
day after fertilization mouse embryos have undergone cell divi-
sion once. During the same period zebraﬁsh embryos have
established a basic body plan and have formed all major
organs. Maybe most miRNAs are not produced fast enough,
miRNA levels are to low or miRNA action is to slow to func-
tion in the rapid dividing cells of early zebraﬁsh embryos.
Alternatively, other RNAi-related mechanisms that are con-
trolled by Dicer, such as the formation of heterochromatin
structures and centromeric silencing [117,121], may have a
function in early development of mice, but not in zebraﬁsh.
The only miRNAs that are highly expressed during early
zebraﬁsh development are members of the miR-430 miRNA
family. The miR-430 miRNA family is expressed from a geno-
mic cluster of more than 90 copies within 120 kb, is conserved
in other ﬁsh species and related miRNAs are present in mam-
mals and frogs [29,31,120]. In frogs, these related miRNAs are
also expressed early in development [29]. Injection of miR-430
into maternal-zygotic dicer mutant zebraﬁsh embryos rescues
the brain morphogenesis defects and to some extend the other
neuronal defects, indicating that the miR-430 miRNA family
regulates neurogenesis in zebraﬁsh [120].4.6. Late vertebrate development
Some other miRNAs have a more specialized function at
later stages of vertebrate development (Table 1). First,
miR-196 is involved in HOX gene regulation. The mir-10 and
mir-196 genes of various vertebrates reside in the homeobox
(HOX) clusters. Like the HOX genes, miR-10 and miR-196
are colinearly expressed in time and space along the anteriopos-
terior (head-to-tail) body axis [42,89]. In 15-day-old mouse
embryos, miR-196 directs cleavage of HOXB8 mRNA and
probably also inhibits theHOXC8,HOXD8 andHOXA7 genes
[90]. The expression of miR-196 is somewhat more posterior
than the target HOX genes [89], which probably helps to deﬁne
the posterior expression-boundary of the target HOX genes
[90]. miR-10 may have a similar function in the HOX cluster
since target sites for mir-10 have also been predicted in HOX
genes, for example in HOXA3 [11]. Second, the muscle-speciﬁc
miR-1 regulates the balance between diﬀerentiation and proli-
feration of cardiomyocytes during heart development in mice
[122]. Overexpression of miR-1 in the heart of transgenic mice
results in a proliferation defect and failure of ventricular
cardiomyocyte expansion, indicative of premature diﬀerentia-
tion of cardiomyocytes. Hand2, a transcription factor that
promotes ventricular cardiomyocyte expansion is a target of
miR-1. Hand2 is downregulated by overexpression of miR-1
in vivo, suggesting that it is a true target during mouse heart
development [122]. Third, the miR-181 miRNA modulates
hematopoietic lineage diﬀerentiation in mice. miR-181 is pre-
ferentially expressed in B-lymphocytes of mouse bone marrow
and the thymus, the primary lymphoid organ [42,47]. Ectopic
overexpression of miR-181 increases the fraction of B-lympho-
cytes and decreases the fraction of T-lymphocytes in vitro andin vivo in mice. Although the target for miR-181 is not known,
this indicates that miR-181 regulates mouse hematopoietic
lineage diﬀerentiation [47]. Fourth, miR-143 regulates human
adipocyte diﬀerentiation. miR-143 is strongly expressed in
adipose (fat) tissue and is upregulated during the diﬀerentiation
of human pre-adipocytes into adipocytes. Knockdown of miR-
143 prevents adipocyte-speciﬁc gene expression and the accu-
mulation of triglycerides but increases ERK5 protein levels
[123]. ERK5 is a predicted target gene of miR-143 [124]. These
data suggest that miR-143 is normally involved in promoting
adipocyte diﬀerentiation or functioning, possibly through the
regulation of ERK5 protein levels [123]. Finally, some miRNAs
may have a role in imprinting during development. Themir-127
andmir-136 genes reside in the human imprinted 14q32 domain
and are expressed from the maternally inherited chromosome,
in the antisense orientation to a retrotransposon-like gene
(Rtl1), which is exclusively expressed from the paternal chro-
mosome. Lack of maternal gene expression in this region has
been associated with abnormal development in mouse and hu-
mans [125,126].4.7. Physiological functions of vertebrate miRNAs
Several miRNAs do not have an obvious role in vertebrate
development, but rather act in diverse physiological and cel-
lular processes (Table 1). The miR-375 miRNA is speciﬁcally
expressed in murine pancreatic islets cells, where it regulates
the Myotrophin (Mtpn) gene and thereby glucose-stimulated
insulin exocytosis [46]. Recently, it has been shown that
miR-375 may act synergistically with miR-124a and let-7b
[102]. Besides expression in the pancreatic islets, miR-375 is
also highly expressed in the pituitary gland of zebraﬁsh
embryos [42]. This may indicate a role for miR-375 in the
secretion of other hormones or neuroendocrine products,
perhaps by regulating Mtpn in the pituitary gland. A role
for miR-122a is the exclusion of cationic amino acid trans-
porter (CAT-1) protein from the liver through translation
inhibition and mRNA cleavage [127]. miR-122a is highly
expressed in adult livers and its expression is upregulated
during mammalian liver development. The expression pattern
of CAT-1, a target of miR-122a, is inversely correlated with
miR-122a expression and thus absent from the liver
[23,127]. The functional consequence of this absence is
however unknown. miR-122a may also have a role in mouse
spermatogenesis. miR-122a is diﬀerently expressed in mouse
testis during spermatogenesis and here probably regulates
the target gene Transition protein 2 (Tnp2). Tnp2 is a post-
transcriptionally regulated testis-speciﬁc gene that is involved
in chromatin remodeling during mouse spermatogenesis [128].
miRNA knockdown experiments indicate that several other
miRNAs have roles in cell proliferation, cell growth and cell
death in cell cultures [98,129]. For example, inhibition of
miR-125b results in decreased proliferation of diﬀerentiated
cancer cells [98]. Recently, it has been shown that miR-16
acts together with AU-rich element (ARE)-binding proteins
in the degradation of ARE-containing mRNAs [130]. AREs
are located in the 3 0 UTR of various short-lived mRNAs
such as those encoding cytokines and proto-oncogenes.
Rapid decay of reporter constructs containing these AREs
requires proteins of the miRNA machinery. The human
miR-16 has only limited complementarity to AREs. However,
in the presence of the ARE-binding protein, tristetraprolin
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ARE containing mRNAs. Knockdown and overexpression
of miR-16 inhibits and promotes degradation of ARE
containing mRNAs, respectively [130]. The miR-16-depen-
dent regulation of ARE mRNAs by ARE-binding proteins
suggests that we might expect several miRNAs to have a
variety of potential activities as speciﬁcity factors for the
interaction of mRNA regulatory proteins.4.8. General function of miRNAs
Thus far miRNAs have only been identiﬁed in multicellular
organisms and are notably absent from unicellular organisms.
This absence indicates that miRNAs, in general, may be essen-
tial for organisms to diﬀerentiate into multiple cell- and tissue
types and/or to keep cells in a particular diﬀerentiation state.
Several recent observations suggest that miRNAs are indeed
such regulators of diﬀerentiation. First, undiﬀerentiated or
poorly diﬀerentiated cells do not require miRNAs to survive.
This is apparent from the fact that mouse ES cells that do
not form miRNAs are viable but fail to diﬀerentiate [117]
and zebraﬁsh germ cells do not need miRNAs for their survival
and contribution to the germ line [120]. Second, most miRNAs
are not expressed in early zebraﬁsh development when cells are
undiﬀerentiated [31,42], but have highly tissue-speciﬁc expre-
ssion at later stages when the most of cell types have been
formed [42]. Third, in agreement with this absence, miRNAs
are also not essential for tissue fate establishment during early
zebraﬁsh development, but are essential for later developmen-
tal steps [120] and tissue growth and/or functioning [119].
Fourth, many types of human cancer cells have reduced miR-
NA expression compared to their fully diﬀerentiated tissue of
origin [131]. Fifth, vertebrate animals encode hundreds diﬀer-
ent miRNAs that are expected to regulate up to 30% of the
genes [10,11]. Many of these miRNAs are widely conserved.
Sixth, miRNAs have a high molecular abundance per cell. In
C. elegans some miRNAs have been estimated to be present
in as many as 50000 copies per cell, which is approximately
500-fold higher than the level of a typical worm mRNA [34].
Finally, transfection of the muscle-speciﬁc miR-1 and the
brain-speciﬁc miRNA miR-124 into human HeLa cells shift
the mRNA expression proﬁle to that of muscle and brain cells,
respectively [132].
From an evolutionary point of view, the regulation of gene
expression by miRNAs may be an easy and ﬂexible innova-
tion, nevertheless crucial for cellular diﬀerentiation. The small
size and simplicity of miRNA genes suggests that they can
arise relatively easily and frequently de novo in animal and
plants genomes. The independent creation of miRNAs is
reﬂected by the high diversity between miRNA families and
the lack of overlap between plant and animal miRNAs
[133,134]. Furthermore, a few DNA base-pair changes corre-
sponding to the seed sequences of miRNAs are likely to con-
siderably alter the repertoire of target genes. In parallel,
target genes can easily be subsumed under the control of
miRNAs through changes of only a few base-pairs in the
DNA corresponding to their 3 0 UTRs, similar to the acquisi-
tion of cis-regulatory sites in the promoters of genes. Single
miRNAs are able to regulate about hundred target genes
[132] and the combinatorial action of miRNAs is expected to
regulate the expression of thousands of mRNAs [133]. The
dampening of such a number of genes might be essential forthe initiation or maintenance of tissue diﬀerentiation
[42,133]. In addition, the post-transcriptional regulation of
gene expression might also dampen ﬂuctuations in gene expres-
sion. This dampening results in stable protein levels, which
might also be required to keep cells diﬀerentiated.5. MicroRNAs and disease
The high number of miRNA genes, the diverse expression
patterns and the abundance of potential miRNA targets suggest
that miRNAs are likely to be involved in a broad spectrum of
human diseases. In addition, components required for miRNA
processing and/or function have also been implicated in fragile
X mental retardation [135], DiGeorge syndrome [58–60] and
cancer [136], pointing at a general involvement of miRNAs in
disease.5.1. miRNAs and cancer
More than half of the human miRNA genes are located at
sites known to be involved in cancers, such as fragile sites, min-
imal regions of loss of heterozygosity, minimal regions of
ampliﬁcation, or common breakpoint regions. Such locations
suggest that some miRNAs are involved in tumorigenesis [43].
miRNA expression proﬁles of a large number of human tumor
samples show that miRNAs are sometimes upregulated [43],
but generally downregulated in tumors [131]. Furthermore,
nearly all miRNAs are diﬀerentially expressed in diﬀerent
cancers. Since the miRNA proﬁles reﬂect the developmental
lineage and diﬀerentiation state of tumors, these proﬁles can
be used to classify poorly diﬀerentiated tumors [131]. The
roles for some miRNAs have been investigated in more detail
(Table 1).
The cluster of the mir-15 and mir-16 genes lies in a region
that is deleted in more than half of B-cell chronic lymphocyte
leukemias and expression of miR-15 and miR-16 is downregu-
lated in the majority of these leukemias [137]. The mir-143 and
mir-145 genes also reside in a genomic cluster. Expression of
both miRNAs is downregulated in colon cancer tissue as well
as in several cell lines derived from other types of cancers [138].
The mir-155 gene lies in the non-coding BIC RNA transcript.
Both the expression of BIC RNA and miR-155 are upregu-
lated in several types of lymphomas, especially in diﬀuse large
B-cell lymphomas [139,140]. Patients with activated B-cell
lymphomas have worse prognosis than patients with germinal
center lymphomas, which is reﬂected by the absolute levels of
miR-155 in these cancers [140]. The human let-7 miRNA is
downregulated in several lung cancers and is able to inhibit
growth of lung cancer cells in vitro [111,141]. In addition,
let-7 levels are lowest in patients with the lowest postoperative
survival; thus, let-7 is also a good indicator for the prognosis of
these types of cancers. The mir-17-92 cluster is located in a
region that is often ampliﬁed in human B-cell lymphomas
and miRNA levels from this cluster are increased in B-cell
lymphomas. Overexpression of the mir-17-92 cluster prevents
apoptosis and accelerates the formation of c-Myc-induced
B-cell lymphomas in mouse models [142]. Interestingly,
c-Myc itself also upregulates the expression of miRNAs from
the mir-17-92 cluster and the cell cycle promoter E2F1, a target
for some of these miRNAs, resulting in a tightly controlled
proliferative signal [143].
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miRNAs have been identiﬁed in several mammalian viruses,
including many members of the herpesvirus family [32], such as
Epstein-Barr virus [33] and Kaposi sarcoma-associated virus
[144], simian virus 40 [145] and possibly the human immunode-
ﬁciency virus [146]. For most of these miRNAs the functions
are unknown, but they are expected to regulate the expression
of viral and host genes for their survival and propagation in
infected cells. For example, two miRNAs encoded by simian
virus 40 target early viral mRNAs for cleavage. This reduces
the expression of the viral T antigens, which makes the infected
cells less susceptible to cytotoxic T cells and thus enhances the
probability of successful infection [145]. Recently it has also
been shown that endogenous miRNAs can mediate antiviral
defense. The endogenous miR-32 prevents the accumulation
of the retrovirus primate foamy virus type 1 (PFV-1) in human
cells. However, a PFV-1-encoded protein, Tas, is able to par-
tially suppress the miRNA-induced inhibition of PFV-1 [97].
Together, this indicates that the miRNA machinery is involved
various aspects of human viral infections.6. Conclusions
Since the discovery of lin-4 and let-7 it has become apparent
that miRNAs form an important and abundant class of post-
transcriptional gene regulators, which are widely present in
multicellular organisms, ranging from plants to humans. Ani-
mals encode hundreds of miRNAs, of which the vast majority
have unknown functions. Nevertheless, the limited set of char-
acterized miRNAs indicates that miRNAs can act in diverse
biological processes. In addition, mice and zebraﬁsh which
are defective in miRNA production or function show that
miRNAs are essential for vertebrate development, and are
likely to be involved in diﬀerentiation and/or maintenance of
tissue and cell identity. The current set of miRNAs is predicted
to regulate several thousands of target mRNAs, which may go
up to 30% of all protein-coding genes [10,11,101]. This number
might still increase because many additional miRNAs are pre-
dicted, even up to a thousand in vertebrate genomes [9]. The
veriﬁcation of the existence of these miRNAs and their interac-
tion with target genes will be the key to ﬁnd the function of all
individual miRNAs during development, disease and other
cellular processes.
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